热景生物
(688068)
| 流通市值：60.06亿 | | | 总市值：60.06亿 |
| 流通股本：9275.41万 | | | 总股本：9275.41万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 374,967,108.06 | 267,742,855.53 | 116,025,958 | 404,875,328.83 |
| 营业总成本 | 640,450,678.1 | 425,798,962.15 | 205,096,020.9 | 658,410,281.34 |
| 其他经营收益 | | | | |
| 营业利润 | -274,939,125.03 | -158,625,106.46 | -82,241,883.49 | -264,897,517.86 |
| 利润总额 | -274,913,188.29 | -159,611,633.03 | -82,671,395.74 | -267,275,739.98 |
| 净利润 | -272,673,046.99 | -158,809,512.56 | -82,665,618.04 | -258,634,919.3 |
| 每股收益 | | | | |
| 其他综合收益 | 30,057,400.91 | 29,799,414.12 | 2,708,234.04 | 13,420,525.92 |
| 综合收益总额 | -242,615,646.08 | -129,010,098.44 | -79,957,384 | -245,214,393.38 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,326,892,437.97 | 1,455,679,790.9 | 1,486,228,427.69 | 1,596,987,040.89 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,619,927,370.34 | 1,607,940,624.55 | 1,604,860,449.05 | 1,582,893,150.57 |
| 资产总计 | 2,946,819,808.31 | 3,063,620,415.45 | 3,091,088,876.74 | 3,179,880,191.46 |
| 流动负债: | | | | |
| 流动负债合计 | 165,889,782.55 | 179,069,293.37 | 220,593,963.02 | 248,032,642.57 |
| 非流动负债: | | | | |
| 非流动负债合计 | 297,809,226.22 | 293,955,386.61 | 278,891,166.91 | 275,254,908.24 |
| 负债合计 | 463,699,008.77 | 473,024,679.98 | 499,485,129.93 | 523,287,550.81 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,360,826,022.97 | 2,441,692,411.98 | 2,432,022,948.18 | 2,486,270,782.99 |
| 股东权益合计 | 2,483,120,799.54 | 2,590,595,735.47 | 2,591,603,746.81 | 2,656,592,640.65 |
| 负债和股东权益合计 | 2,946,819,808.31 | 3,063,620,415.45 | 3,091,088,876.74 | 3,179,880,191.46 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 379,427,203.72 | 311,830,581.85 | 95,880,455.8 | 514,397,450.58 |
| 经营活动现金流出小计 | 563,604,992.18 | 423,560,057.06 | 156,317,986.08 | 597,754,273.75 |
| 经营活动产生的现金流量净额 | -184,177,788.46 | -111,729,475.21 | -60,437,530.28 | -83,356,823.17 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,831,037,129.88 | 1,440,000,526.56 | 919,697,786.32 | 4,995,780,544.64 |
| 投资活动现金流出小计 | 1,995,236,283.84 | 1,648,460,530.76 | 1,208,129,833.5 | 4,746,863,498.85 |
| 投资活动产生的现金流量净额 | -164,199,153.96 | -208,460,004.2 | -288,432,047.18 | 248,917,045.79 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 101,682,327.03 | 106,275,682.02 | 8,225,396.97 | 358,861,862.71 |
| 筹资活动现金流出小计 | 101,372,849.76 | 114,753,613.6 | 51,761,761.69 | 271,086,794.66 |
| 筹资活动产生的现金流量净额 | 309,477.27 | -8,477,931.58 | -43,536,364.72 | 87,775,068.05 |
| 汇率变动对现金及现金等价物的影响 | -2,198,144.98 | 1,273,186.1 | -3,806,802.41 | 1,457,033.75 |
| 现金及现金等价物净增加额 | -350,265,610.13 | -327,394,224.89 | -396,212,744.59 | 254,792,324.42 |
| 期末现金及现金等价物余额 | 186,567,754.59 | 209,439,139.83 | 111,327,421.44 | 536,833,364.72 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -327,394,224.89 | - | 254,792,324.42 |
最新报告期：2026-08-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东吴证券 | 朱国广 | -0.63 | 0.08 | 0.72 | 2026-08-30 |